BioNeutra Global Valuation
| BGACF Stock | USD 0.07 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. BioNeutra Global prevailing Real Value cannot be determined due to lack of data. The current price of BioNeutra Global is $0.067. Our model approximates the value of BioNeutra Global from analyzing the firm fundamentals such as Current Valuation of 5 M, profit margin of (0.16) %, and Return On Equity of -2.55 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that BioNeutra Global's price fluctuation is out of control at this time. Calculation of the real value of BioNeutra Global is based on 3 months time horizon. Increasing BioNeutra Global's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioNeutra pink sheet is determined by what a typical buyer is willing to pay for full or partial control of BioNeutra Global. Since BioNeutra Global is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioNeutra Pink Sheet. However, BioNeutra Global's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.067 | Real 0.0 | Hype 0.0 | Naive 0.067 |
The real value of BioNeutra Pink Sheet, also known as its intrinsic value, is the underlying worth of BioNeutra Global Company, which is reflected in its stock price. It is based on BioNeutra Global's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BioNeutra Global's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BioNeutra Global helps investors to forecast how BioNeutra pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioNeutra Global more accurately as focusing exclusively on BioNeutra Global's fundamentals will not take into account other important factors: BioNeutra Global Total Value Analysis
BioNeutra Global is currently forecasted to have takeover price of 5 M with market capitalization of 863.36 K, debt of 6.34 M, and cash on hands of 1.93 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioNeutra Global fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5 M | 863.36 K | 6.34 M | 1.93 M |
BioNeutra Global Investor Information
About 37.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.02. BioNeutra Global had not issued any dividends in recent years. Based on the analysis of BioNeutra Global's profitability, liquidity, and operating efficiency, BioNeutra Global is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.BioNeutra Global Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioNeutra Global has an asset utilization ratio of 73.04 percent. This implies that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that BioNeutra Global is more efficient with each dollar of assets it utilizes for everyday operations.BioNeutra Global Ownership Allocation
BioNeutra Global holds a total of 46.45 Million outstanding shares. BioNeutra Global retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioNeutra Global Profitability Analysis
The company reported the revenue of 15.4 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 2.89 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioNeutra Global's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioNeutra Global and how it compares across the competition.
About BioNeutra Global Valuation
The pink sheet valuation mechanism determines BioNeutra Global's current worth on a weekly basis. Our valuation model uses a comparative analysis of BioNeutra Global. We calculate exposure to BioNeutra Global's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioNeutra Global's related companies.BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. Bioneutra Global is traded on OTC Exchange in the United States.
8 Steps to conduct BioNeutra Global's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioNeutra Global's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioNeutra Global's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioNeutra Global's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioNeutra Global's revenue streams: Identify BioNeutra Global's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioNeutra Global's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioNeutra Global's growth potential: Evaluate BioNeutra Global's management, business model, and growth potential.
- Determine BioNeutra Global's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioNeutra Global's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BioNeutra Global Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioNeutra Global does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.4 M | |
| Retained Earnings | -11 M |
Complementary Tools for BioNeutra Pink Sheet analysis
When running BioNeutra Global's price analysis, check to measure BioNeutra Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNeutra Global is operating at the current time. Most of BioNeutra Global's value examination focuses on studying past and present price action to predict the probability of BioNeutra Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNeutra Global's price. Additionally, you may evaluate how the addition of BioNeutra Global to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |